Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Eli Lilly treatment solanezumab failed to slow disease Finances March 9, 2023 Eli Lilly on Wednesday mentioned it can halt improvement of its Alzheimer’s remedy candidate solanezumab after the antibody didn’t sluggish…
